Title
Category
Credits
Event date
Cost
  • Participation
$350.00
                                                                                    
  • Participation
$350.00
                                                                                    
  • Participation
$35.00
Welcome to the HESI ITC On-demand training course. We are delighted that you have chosen to enhance your  educational journey in immuno-safety science by enrolling in this  course. The "Overview of Cancer Immunotherapies" course  is 1 of 10 courses included in the Cancer Immunotherapies Module  and is led by Dr .Robert Johnston  PhD - Cancer Immunologist at Genentech.  
$25.00
The "Cytokine Release " course  is 1 of 10 courses included in the Cancer Immunotherapies Module  and is led by Dr. Madeline Fort, PhD- at  Amgen
$25.00
The "Assessing Risk of Adverse Pregnancy Outcomes for Immuno-Oncology Programs" is 1 of 10 courses included in the Cancer Immunotherapies module. This course is led by Dr. Curtis Maier Director at Glaxo Smith Kline
  • Participation
$25.00
The "Nonclinical Safety assessment of therapies targeting neoantigens" is 1 of 10 courses included in the Cancer Immunotherapies module. This course is led by Dr. Gautham Rao at Genentech 
$25.00
The "Quantitative systems pharmacology /toxicology modeling for IO therapies" is 1 of 10 courses included in the Cancer Immunotherapies module. This course is led by Dr. Roy song at Glaxo Smith Kline
$25.00
The "Neurotoxicity across Cancer Modalities" course is 1 of 10 courses included in the Cancer Immunotherapies module. This course is led by Dr. Juliane Gust, MD at Seattle Children Hospital
$25.00
The "Regulatory Considerations for Cancer Immunotherapies:​ Preclinical Focus​" course is one of 18 course in the Introduction to Immuno- Safety Science.  This course is led by Dr. Mary Ellen Cosenza, Ph.D. DABT, ERT, RAC, ATS​ - at Toxicology consulting.
$25.00
The "Natural Killer Cells and their for Cancer Immunotherapy " course  is 1 of 10 courses included in the Cancer Immunotherapies Module  and is led by Dr.  Alexandre Iannello - at Sonoma Biotherapeutics

Pages